Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Other Pulmonary Disorders01:17

Other Pulmonary Disorders

1.5K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.5K
Pneumothorax-II01:27

Pneumothorax-II

905
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
905
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

534
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
534

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GLP-1 Receptor Agonist Effect on Disease Severity in Idiopathic Subglottic Stenosis.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026
Same author

Idiopathic Subglottic Stenosis in Pregnancy: A Case-Control Study of Management and Maternal Safety.

The Laryngoscope·2026
Same author

In Response to Multi-Institutional Endoscopic Resection and Reconstitution for Idiopathic Subglottic Stenosis.

The Laryngoscope·2026
Same author

Diagnosis and Treatment of Refractory Chronic Cough: An American Broncho-Esophagological Association Expert Consensus Statement.

The Laryngoscope·2026
Same author

High Utilizers of MyChart Electronic Patient Portal Messaging in A Head and Neck Surgery Clinic.

The Laryngoscope·2026
Same author

Machine Learning of Acoustic Voice Outcomes in Idiopathic Subglottic Stenosis.

The Laryngoscope·2026

Related Experiment Video

Updated: Jan 15, 2026

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA

Published on: December 19, 2019

15.3K

Prolonged Treatment Gaps and Recurrence Patterns in Recurrent Respiratory Papillomatosis.

Sarah Gao1, Raymond J So1, Ronit Malka1

  • 1Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

The Laryngoscope
|October 7, 2025
PubMed
Summary

Recurrent respiratory papillomatosis (RRP) patients can experience long remission periods before recurrence. Identifying these patients is challenging, emphasizing the need for new immunologic treatments targeting the chronic HPV infection.

Keywords:
immunologic therapyrecurrence patternsrecurrent respiratory papillomatosistreatment gaps

More Related Videos

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.1K
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

23.7K

Related Experiment Videos

Last Updated: Jan 15, 2026

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA

Published on: December 19, 2019

15.3K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.1K
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

23.7K

Area of Science:

  • Otolaryngology
  • Immunology
  • Viral Diseases

Background:

  • Recurrent respiratory papillomatosis (RRP) presents an unpredictable disease course with potential for late recurrences.
  • Human papillomavirus (HPV) is the causative agent, and chronic infection necessitates novel immunologic strategies.
  • Understanding recurrence patterns is crucial for managing RRP and developing effective therapies.

Purpose of the Study:

  • To investigate recurrence patterns in RRP patients.
  • To identify clinical variables associated with prolonged remission periods.
  • To inform the development of targeted immunologic interventions for chronic HPV infection in RRP.

Main Methods:

  • Retrospective chart review of RRP patients treated since 2003.
  • Analysis of surgical history and disease status during treatment-free intervals.
  • Comparative analysis of patient and disease characteristics using chi-squared and Fisher's exact tests.

Main Results:

  • Over 22% of RRP patients experienced a treatment gap of at least 4 years, with nearly 14% having gaps over 10 years.
  • Patients with prolonged treatment gaps (≥4 years) were more likely to have undergone surgery (100%) versus office procedures and less likely to have supraglottic disease (17.5%).
  • No significant differences were found in sex, age of onset, or other clinical characteristics between patients with and without prolonged treatment gaps.

Conclusions:

  • A significant subset of RRP patients experience recurrence after extended treatment-free periods.
  • Predicting this cohort based on current clinical characteristics remains difficult.
  • The findings underscore the critical need for immunologic strategies to eradicate the underlying chronic HPV infection.